Abropernol N, 50 pcs

Instructions for use for Abropernol N, 50 pcs

Important notes (compulsory information):

Abropernol n, tablets. Areas of application: The fields of application are derived from the homeopathic medicament images. These include: inflammatory and eczema-eating skin diseases.

For risks and side effects, read the package leaflet and ask your doctor or pharmacist.


LEAFLET: INFORMATION FOR THE USER

Abropernol n, tablets

Indication group:
Homeopathic medicine in skin diseases.

Application areas:
The fields of application are derived from the homeopathic pharmaceutical images. These include: inflammatory and eczema-eating skin diseases.

Contraindications:
Do not use in pregnancy and lactation. Do not use in children under 6 years.

Precautions for the application:
For persistent, unclear or new complaints, you should consult your doctor. To apply this medicine in children from 6 years to under 12 years, there are no sufficiently documented experiences. It should therefore be in children from 6 Years until under 12 years are not applied.

Interactions:
Not known. General Note: The effect of a homeopathic drug can be unfavorably influenced by generally damaging factors in the way of life and stimulus and enjoyment. If you apply other medicines, ask your doctor.

Warnings:
This medicine contains lactose! Please take the medicine after consultation with your doctor if you are known to suffer from sugar intolerance. 1 tablet = 0.025 BE.

Duration of treatment:
Homeopathic medicines should not be applied for a long time without a medical advice.

Notes for the application:
Do not apply twice the dose if you forget the previous application. If you have further questions about the application of the medicine, ask your doctor or pharmacist.

Side effects:
Not known. Note: When using a homeopathic medicinal product, the existing complaints may be temporarily worn out (initial worstization). In this case, you should discontinue the medicine and consult your doctor. If you notice side effects, contact your doctor or pharmacist. This also applies to side effects that are not indicated in this leaflet. You can also add side effects directly to the Federal Institute for Medicines and Medical Devices, Dept. Pharmacovigilance, Kurt-Georg-Kiesinger-Allee 3, D-53175 Bonn, Website: www.bfarm.de. By reporting side effects, you can help to provide more information about the security of this medicine.

Notes on expiration date and storage:
The expiration date of this pack is printed on container and outer wrapper. Do not use this pack after this date! After opening, use within 12 months. No special storage conditions are required for this medicine.

Composition:
1 tablet contains: active ingredients: Artemisia Abrotanum Trit. D4 60 mg, Pulsatilla Pratensis Trit. D4 60 mg, Calcium Fluoratum Trit. D12 60 Mg, Petroleum Rectificatum Trit. D6 30 mg, agaricus (have 34) trit. D5 (HAB, Regulation 3a) 30 mg, Acidum Nitricum Trit. D8 30 mg, Hamamelis Virginiana Trit. D4 30 mg. Joint potentiation over the last 2 levels as a tender. Other component: Magnesium stearate.

Pack sizes:
50 tablets.

Pharmaceutical entrepreneur and manufacturer:
Biologische Heilmittel Heel GmbH
Dr.-ReceWeg-Str. 2-4
76532 Baden-Baden
Telephone: 07221 501-00
Fax: 07221 501-210
E-Mail: [email protected]

Status of Information: November 2015

Source: Information of the leaflet
Status: 04/2016